Yoshihide Asano
www.mendeley.com
0000-0001-5560-9778
University of Tokyo
23 papers found
Refreshing results…
Analysis of surgical margins and prognostic factors in dermatofibrosarcoma protuberans after wide local excision: A multicenter study of 116 Japanese patients
Staphylococcus aureus skin colonization promotes SLE-like autoimmune inflammation via neutrophil activation and the IL-23/IL-17 axis
The Contribution of LIGHT (TNFSF14) to the Development of Systemic Sclerosis by Modulating IL-6 and T Helper Type 1 Chemokine Expression in Dermal Fibroblasts
Fli1 deficiency suppresses RALDH1 activity of dermal dendritic cells and related induction of regulatory T cells: a possible role in scleroderma
Altered Properties of Endothelial Cells and Mesenchymal Stem Cells Underlying the Development of Scleroderma‐like Vasculopathy in KLF5+/−;Fli‐1+/− Mice
Serum S100A12 levels: possible association with skin sclerosis and interstitial lung disease in systemic sclerosis
Decreased serum cathepsin S levels in patients with systemic sclerosis‐associated interstitial lung disease
Clinical significance of endothelial vasodilatory function evaluated by EndoPAT in patients with systemic sclerosis
Unique correlation profile of adiponectin and retinol‐binding protein 4 in patients with systemic sclerosis
Possible association of decreased serum CXCL14 levels with digital ulcers in patients with systemic sclerosis
A potential contribution of decreased galectin‐7 expression in stratified epithelia to the development of cutaneous and oesophageal manifestations in systemic sclerosis
Estrogen dermatitis: Case report and examination of estrogen receptor-β in the skin
Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study
An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis
CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis
Diagnostic criteria, severity classification and guidelines of systemic sclerosis: Guideline of SSc
Diagnostic criteria, severity classification and guidelines of localized scleroderma
Impact of a new simplified disability scoring system for adult patients with localized scleroderma
Systemic sclerosis
Possible pro-inflammatory role of heparin-binding epidermal growth factor-like growth factor in the active phase of systemic sclerosis
Missing publications? Search for publications with a matching author name.